SRC and prostate carcinoma: Another study indicated that two naturally occurring sesquiterpenoids (ST1 and ST2) could inhibit the expression of SRC-1 and AR in prostate cancer cells and suppress the nuclear transport of AR, further inhibiting the interaction between SRC-1 and AR [105].